Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study

M.E. van der Valk, M.J.J. Mangen, M. Leenders, G. Dijkstra, A.A. van Bodegraven, H.H. Fidder, D.J. de Jong, M. Pierik, C.J. van der Woude, M.J.L. Romberg-Camps, C.H.M. Clemens, J.M. Jansen, N. Mahmmod, P.C. van de Meeberg, A. Jong, C.Y. Ponsioen, C.J.M. Bolwerk, J.R. Vermeijden, P.D. Siersema, M.G.H. van OijenB. Oldenburg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)72-79
Issue number1
Publication statusPublished - 2014

Cite this